According to the website of the National Medical Products Administration, Shanghai Xinwei Medical Technology Co., Ltd.'s "intracranial aneurysm embolization assisted stent" and Yabonixi Medical Technology (Suzhou) Co., Ltd.'s "knee joint prosthesis system" have been approved for market launch.

 

 

 

Among them, Xinwei Medical's innovative product of "Intracranial Aneurysmal Embolization Assist Stent" consists of three parts: stent, delivery guide wire, and introduction sheath. The stent part is made of nickel titanium alloy tube by laser engraving, and there are platinum iridium imaging points at both ends of the stent and in the middle of some models, which facilitate accurate clinical judgment of stent opening and adhesion. Under clinical standard interventional surgical conditions, the location of intracranial aneurysms is determined based on angiography, which is used for intravascular embolization and blood flow reconstruction in patients with intracranial aneurysms.

 

 

 

Yabonisi's innovative knee prosthesis system consists of femoral, tibial, and patellar components, suitable for first-time knee replacement surgery in patients with mature bone development. Among them, the interface between the femoral condyle and tibial tray and the bone is composite with a porous structure of bone trabeculae made by additive manufacturing technology, which has high friction coefficient and good bone bonding performance.

 

 

 

According to the data, as a domestic enterprise in the field of neurointerventional medical devices, Xinwei Medical's core development strategy has also shifted from homogeneous pathway products to therapeutic products. The differentiated layout provides strong support for the company's subsequent growth. Data shows that as of now, the company has 30 device products approved for market by NMPA, covering a wide range of treatments for acute ischemic stroke and neurovascular stenosis, hemorrhagic stroke, ischemic stroke prevention, interventional pathways, and peripheral interventional devices.

 

 

 

At the same time, Xinwei Medical continues to develop more heavyweight products. It is expected that at least five heavyweight neurointerventional therapy devices will be launched in the next 18 months, including intracranial drug-eluting balloon catheters (NMPA innovative device qualification), self expanding drug-eluting stents, and carotid stents for stenosis treatment, arterial aneurysm embolization assist stents (NMPA innovative device qualification) for hemorrhagic stroke treatment, and blood flow guidance devices. At the same time, the company is also enhancing the competitiveness of key thrombectomy products (suction catheters and thrombectomy stents) and one-stop medical device solutions to meet the growing demand for stroke treatment in the aging Chinese market for different subtypes of cerebral infarction. The intracranial aneurysm embolization stent approved for market this time has a wider range of product specifications, which will provide clinical doctors with more choices.

 

 

 

Yabonixi Jiaoying Medical Equipment (Shanghai) Co., Ltd., a wholly-owned subsidiary of Yabonixi, is a high-tech medical equipment company that focuses on innovative technology and the high-end market. The company is dedicated to the field of high-end medical equipment and aims to meet the historical opportunity of import substitution in the rapidly growing domestic market with high-quality and cost-effective products. At present, Yabonixi Medical has developed multiple technologies and industrialized products such as artificial hip joints, artificial knee joints, and endoscopic staplers.

 

 

 

The knee prosthesis system approved for market by Yabonixi has achieved multi-directional freedom of movement. The unique design of the femur and ankle is saddle shaped, which increases the stability of the knee joint; The cushion cleverly cooperates with the femur ankle to ensure smooth flexion, extension, sliding, and rotation; The tibial plateau adopts a T-shaped structure to provide reliable fixation support; The lower surface of the platform support adopts a porous structure to promote bone growth and make the prosthesis more stable and durable. With the help of this product, joint movements can be more natural and smooth, providing support for patients to restore their health and mobility.